174 related articles for article (PubMed ID: 36110371)
1. Monomerization of Homodimeric Trefoil Factor 3 (TFF3) by an Aminonitrile Compound Inhibits TFF3-Dependent Cancer Cell Survival.
Pandey V; Zhang X; Poh HM; Wang B; Dukanya D; Ma L; Yin Z; Bender A; Periyasamy G; Zhu T; Rangappa KS; Basappa B; Lobie PE
ACS Pharmacol Transl Sci; 2022 Sep; 5(9):761-773. PubMed ID: 36110371
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma.
Guo H; Tan YQ; Huang X; Zhang S; Basappa B; Zhu T; Pandey V; Lobie PE
Cancer Lett; 2023 Nov; 579():216443. PubMed ID: 37858772
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK.
Chen RM; Chiou YS; Chong QY; Poh HM; Tan TZ; Zhang MY; Ma L; Zhu T; Pandey V; Basappa ; Kumar AP; Lobie PE
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835445
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TFF3 Enhances Sensitivity-and Overcomes Acquired Resistance-to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma.
Poh HM; Chiou YS; Chong QY; Chen RM; Rangappa KS; Ma L; Zhu T; Kumar AP; Pandey V; ; Lee SC; Lobie PE
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31658702
[TBL] [Abstract][Full Text] [Related]
5. Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.
Pandey V; Wu ZS; Zhang M; Li R; Zhang J; Zhu T; Lobie PE
Breast Cancer Res; 2014 Sep; 16(5):429. PubMed ID: 25266665
[TBL] [Abstract][Full Text] [Related]
6. Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells.
Pandey V; Zhang M; You M; Zhang W; Chen R; Zhang W; Ma L; Wu ZS; Zhu T; Xu XQ; Lobie PE
Cell Death Dis; 2018 Nov; 9(12):1147. PubMed ID: 30451834
[TBL] [Abstract][Full Text] [Related]
7. A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma.
Zhang M; Wang B; Chong QY; Pandey V; Guo Z; Chen RM; Wang L; Wang Y; Ma L; Kumar AP; Zhu T; Wu ZS; Yin Z; Basappa ; Goh BC; Lobie PE
Oncogenesis; 2019 Nov; 8(11):65. PubMed ID: 31685806
[TBL] [Abstract][Full Text] [Related]
8. Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.
Kannan N; Kang J; Kong X; Tang J; Perry JK; Mohankumar KM; Miller LD; Liu ET; Mertani HC; Zhu T; Grandison PM; Liu DX; Lobie PE
Neoplasia; 2010 Dec; 12(12):1041-53. PubMed ID: 21170268
[TBL] [Abstract][Full Text] [Related]
9. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.
You ML; Chen YJ; Chong QY; Wu MM; Pandey V; Chen RM; Liu L; Ma L; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Jun; 8(24):39323-39344. PubMed ID: 28445151
[TBL] [Abstract][Full Text] [Related]
10. Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.
Chong QY; You ML; Pandey V; Banerjee A; Chen YJ; Poh HM; Zhang M; Ma L; Zhu T; Basappa S; Liu L; Lobie PE
Oncotarget; 2017 Sep; 8(43):74188-74208. PubMed ID: 29088778
[TBL] [Abstract][Full Text] [Related]
11. Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2.
Lau WH; Pandey V; Kong X; Wang XN; Wu Z; Zhu T; Lobie PE
PLoS One; 2015; 10(11):e0141947. PubMed ID: 26559818
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells.
Pandey V; Zhang M; Chong QY; You M; Raquib AR; Pandey AK; Liu DX; Liu L; Ma L; Jha S; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Sep; 8(44):77268-77291. PubMed ID: 29100386
[TBL] [Abstract][Full Text] [Related]
13. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.
Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE
Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated shRNA interference of trefoil factor 3 blocks cell viability, migration and invasion in the papillary thyroid carcinoma cells.
Wu J; Zhang H; Zhang W; Zhang J; Lin X; Xue G; Gao F
Neoplasma; 2018; 65(2):169-177. PubMed ID: 29534576
[TBL] [Abstract][Full Text] [Related]
15. Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression.
Cheng F; Wang X; Chiou YS; He C; Guo H; Tan YQ; Basappa B; Zhu T; Pandey V; Lobie PE
Cell Death Dis; 2022 Mar; 13(3):265. PubMed ID: 35332126
[TBL] [Abstract][Full Text] [Related]
16. Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation.
Perera O; Evans A; Pertziger M; MacDonald C; Chen H; Liu DX; Lobie PE; Perry JK
Cancer Lett; 2015 May; 361(1):104-11. PubMed ID: 25748388
[TBL] [Abstract][Full Text] [Related]
17. Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients.
Thomsen KG; Lyng MB; Elias D; Vever H; Knoop AS; Lykkesfeldt AE; Lænkholm AV; Ditzel HJ
Breast Cancer Res Treat; 2015 Dec; 154(3):483-94. PubMed ID: 26585578
[TBL] [Abstract][Full Text] [Related]
18. Production of Monoclonal Antibodies against Human Trefoil Factor 3 and Development of a Modified-Sandwich ELISA for Detection of Trefoil Factor 3 Homodimer in Saliva.
Khummuang S; Phanphrom W; Laopajon W; Kasinrerk W; Chaiyarit P; Pata S
Biol Proced Online; 2017; 19():14. PubMed ID: 29151819
[TBL] [Abstract][Full Text] [Related]
19. Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Samrao D; Liu S; DuPont NC; Pejovic T
Gynecol Oncol; 2013 Jul; 130(1):174-80. PubMed ID: 23578537
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells.
Yuan Z; Chen D; Chen X; Yang H; Wei Y
Cancer Cell Int; 2017; 17():7. PubMed ID: 28070169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
